drugset / Trial / NCT02331433
Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of APN1125 when administered as single doses to healthy adult subjects.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-11
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APN1125 | Unknown | — | Oral |